Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

GRAIL Completes PATHFINDER 2 Enrollment And NHS-Galleri Study Visits, Anticipates Results In 2025 And 2026

Author: Benzinga Newsdesk | July 15, 2024 03:28am

GRAIL Completes Enrollment of More Than 35,000 Participants in the PATHFINDER 2 Study;
Results From the First 25,000 Participants Expected in the Second Half of 2025
GRAIL Completes Final Study Visits for the NHS-Galleri Trial; Final Results Expected in 2026

Posted In: GRAL